about
Telemedicine for diabetes care: An Indian perspective - feasibility and efficacyOptimal management of type 2 diabetes in patients with increased risk of hypoglycemiaFear of hypoglycaemia: defining a minimum clinically important difference in patients with type 2 diabetes.Impact of symptomatic hypoglycemia on medication adherence, patient satisfaction with treatment, and glycemic control in patients with type 2 diabetes.Disordered eating behavior in individuals with diabetes: importance of context, evaluation, and classificationLiraglutide in the treatment of type 2 diabetes mellitus: clinical utility and patient perspectives.Experiences of self-monitoring: successes and struggles during treatment for weight loss.Hypoglycemia is more common among type 2 diabetes patients with limited health literacy: the Diabetes Study of Northern California (DISTANCE).Hypoglycemia in type 1 diabetes mellitus.Hypoglycaemia in Type 2 diabetes.Severe hypoglycaemia in drug-treated diabetic patients needs attention: a population-based study.Continuous Glucose Monitoring Systems: A Review.A concept analysis of self-monitoring.Severe hypoglycemia in users of sulfonylurea antidiabetic agents and antihyperlipidemicsTherapy modifications in response to poorly controlled hypertension, dyslipidemia, and diabetes mellitus.Outcomes of adding second hypoglycemic drug after metformin monotherapy failure among type 2 diabetes in Hungary.Genetic modification of primate amniotic fluid-derived stem cells produces pancreatic progenitor cells in vitroEvaluation, intervention, and follow-up of patients with diabetes in a primary health care setting in Brazil: the importance of a specialized mobile consultancy.Clinical experience with insulin detemir in patients with type 2 diabetes from the near East countries.Economic impact of hypoglycemia on healthcare in Spain.Glycemic index and glycemic load of carbohydrates in the diabetes diet.The patient perspective of diabetes care: a systematic review of stated preference research.Rodent animal models: from mild to advanced stages of diabetic nephropathy.Identification of risk factors for suffering fear of hypoglycemia in type 1 Diabetes Mellitus patients.Medical resource use, disturbance of daily life and burden of hypoglycemia in insulin-treated patients with diabetes: results from a European online survey.Response of rat retinal capillary pericytes and endothelial cells to glucose.Psychometric validation of the Hypoglycemia Fear Survey-II (HFS-II) in SingaporeOral glutamine is superior than oral glucose to promote glycemia recovery in mice submitted to insulin-induced hypoglycemiaApproach to managing hypoglycemia in elderly patients with diabetes.Insulin detemir: a new option for the treatment of diabetes.The next generation of artificial pancreas control algorithms.Modern insulins--comment on facts and assumptions in a recent editorial.Immunomodulatory effect of leaf extract of Murraya koenigii in diabetic mice.A Systematic Literature Review and Network Meta-Analysis Comparing Once-Weekly Semaglutide with Other GLP-1 Receptor Agonists in Patients with Type 2 Diabetes Previously Receiving 1-2 Oral Anti-Diabetic Drugs.Glutamine dipeptide and cortisol change the liver glucose metabolism and reduce the severity of insulin-induced hypoglycaemia in untreated T1DM Swiss mice.Self-treating hypoglycaemia: a longitudinal qualitative investigation of the experiences and views of people with Type 1 diabetesThe reality of glycaemic control in insulin treated diabetes: defining the clinical challenges
P2860
Q26773536-A7EAB151-B616-469F-8BA3-686D95FCE636Q27026847-6251996E-50F5-4C53-8780-3BA305B3D7BEQ30438098-7DB5CB08-735A-40A0-B8D5-994BA020E73DQ33573537-6225ABDC-15F1-4AAF-ADBA-5D72AC6DC351Q33683839-55B21023-2C1A-4EEB-A227-DA2E7497930DQ33755744-7556243B-8D0C-4736-ACEE-2CCDA23C6F78Q33792235-14BDAA93-6790-4B86-9F3E-C3EF905C81AEQ34050711-F7B920A7-2DA3-450F-838D-86D2A3A5752EQ34072593-5110D2AC-CD58-4518-89F9-D3BDEEEDE0F8Q34739954-2F91CD3F-1712-4154-AADB-4BF7EDD19979Q35945686-E3CD93DE-B2FA-4D07-B7C6-F1C18EFDB5D5Q36335124-BAE08C81-D587-42AD-8BF1-D17DCA06D8A7Q36711488-2FAA8685-71D1-4076-948F-1F985FFD3C3DQ36788554-2365AE02-CBC2-4842-9E8E-173F54F9A123Q36959582-23F03F82-0204-46BE-A4AE-5201BF114CEDQ37010393-19290733-100D-41F5-BD97-C352F2C36A88Q37051167-7B5F1288-30E5-405D-8EEB-21E39FE0FB1DQ37160418-8D00A8BE-D7A9-4996-A36D-E164022279DCQ37468419-08E97CAD-5F6D-41BE-BC11-EF2648D6EE92Q37820677-3D577381-3C6C-4287-95D8-910C5A2E6CA1Q37827430-744007D9-8002-4D32-BA37-37A76ACB3EA2Q38201315-FAC1BB87-BFF2-4E1F-88B3-8F9C1086EB05Q38242389-D10FAF36-5177-4AB2-B90A-C8FCC4D0EE2BQ39124056-0A753C61-B30D-4F13-818A-19239C232490Q39468591-1E285012-4556-4025-9552-BCBFF43EF0D3Q39629878-D0C9D919-A250-4062-85E9-8A39C5B87F15Q41145513-C2D8FC40-F6CB-4075-8BB6-2EAE9CCCDA09Q42138603-4E0D8EAF-3681-4A3E-BB80-3D51031A167CQ42171306-A4ED6BBF-2E62-482F-A431-B58EFB125A5CQ42519403-F112D81A-5775-4C5D-B387-E574DF594A19Q42598439-C5B8AD0D-EF5D-4B8D-8E35-475BB948F2D2Q43080444-4A82DB31-AA97-47BA-B597-F0D0200F2EEEQ51377198-8B079067-7406-4A92-9BD7-B8ABADEB99BBQ52575496-87FEDC7A-4225-47AB-838A-70C0F39DA3BEQ53708662-08E66372-C675-4422-9D79-D9C25A173E5FQ57412887-81F16822-91AF-4A97-99F7-FE6F98DE05FEQ59311929-0F1EEF92-DC12-42FF-9175-12293AD55FDB
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Hypoglycemia as a barrier to glycemic control.
@ast
Hypoglycemia as a barrier to glycemic control.
@en
type
label
Hypoglycemia as a barrier to glycemic control.
@ast
Hypoglycemia as a barrier to glycemic control.
@en
prefLabel
Hypoglycemia as a barrier to glycemic control.
@ast
Hypoglycemia as a barrier to glycemic control.
@en
P1476
Hypoglycemia as a barrier to glycemic control.
@en
P2093
Miriam D Alonso
Stephen Davis
P356
10.1016/S1056-8727(03)00058-8
P577
2004-01-01T00:00:00Z